Categories: News

Medulla Communications Expands Global Footprint with Strategic Launch in Singapore

New Hub to Deliver Scalable, Specialist Healthcare Marketing Solutions Across APAC

- Advertisement -

MUMBAI, India, Aug. 14, 2025 /PRNewswire/ — Medulla Communications Pvt. Ltd., one of the world’s most awarded healthcare-specialist advertising agencies, has announced the launch of its new hub in Singapore. With over 15 years of experience in solving complex healthcare challenges, Medulla is now looking to create a super-specialist category as the first digital healthcare advertising agency in Asia.

- Advertisement -

Medulla is among the rare agencies globally to win the world’s biggest advertising awards for both creativity and marketing effectiveness in healthcare. It has been named Healthcare Agency of the Year at the Cannes Lions and ranked among the Top 3 Brands of the Year at the APAC Effies. The move reinforces its commitment to delivering high-impact, end-to-end healthcare marketing services—including brand strategy, creative ‘brand love’ campaigns, performance marketing, HCP (healthcare professional) engagement (both virtual and on-ground), CRM, patient support programs (PSPs), and precision-targeted digital campaigns. This expansion also enables Medulla to scale its talent pool and resources more effectively across markets including India.

- Advertisement -

“With over 15 years dedicated to understanding and solving healthcare challenges worldwide—including working with clients in Singapore and Asia—we’re excited to now offer our expertise more directly through a presence on the ground,” said Praful Akali, Founder and Managing Director of Medulla Communications. “We’re passionate about improving lives, and we believe that with our proven capabilities, we’re well-positioned to drive real impact across the region.”

- Advertisement -

Heading Medulla’s APAC operations as Managing Partner is Taffy Ledesma, a seasoned leader with extensive experience across healthcare, FMCG, and agency leadership. Taffy began his career on the client side with Johnson & Johnson, Mead Johnson, and Unilever, before moving into agency leadership roles—most recently as Managing Director at DDB Indonesia and Country Head at Hello Health Group.

- Advertisement -

Speaking about his new role, Taffy said:
“My experience across both client and agency ecosystems gives me a unique lens to truly partner with brands—ensuring their healthcare innovations reach the people they’re meant for. Commercial effectiveness is my core focus, because that’s what makes healthcare communication truly meaningful.”

- Advertisement -

Medulla has had the privilege of partnering with some of the world’s leading global companies including Pfizer, Novartis, Ferring, Mylan, Braintap, Bayer, Kenvue, Big Muscles, IAPC, Muscle Blaze and more. With this expansion, Medulla is poised to further its mission of delivering transformative healthcare marketing solutions across new frontiers.

- Advertisement -

About Medulla Communications:

- Advertisement -

Founded by Praful Akali in 2008, Medulla Communications has consistently been recognized as one of the top healthcare agencies globally. The agency has been honoured as the #1 Healthcare Agency of the Year at Cannes Lions in 2016 and secured a top three global ranking for three consecutive years (2015–2017).

- Advertisement -

Medulla has also been ranked as the #4 Most Effective Independent Agency globally by Effies, and the #4 Most Effective Specialist Agency globally by WARC.

- Advertisement -

For media inquiries, please contact: press@medulla.in | Website: www.medulla.agency

- Advertisement -

Photo: https://mma.prnewswire.com/media/2749782/Medulla_Communications_Team.jpg

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.com/in/news-releases/medulla-communications-expands-global-footprint-with-strategic-launch-in-singapore-302529784.html

- Advertisement -

Recent Posts

Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: Ocular Therapeutix, Inc. BEDFORD, Mass., Feb. 06, 2026…

1 hour ago

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI,…

1 hour ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing…

1 hour ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies

AlUla, Saudi Arabia, Feb. 7, 2026 /PRNewswire/ -- The second edition of the AlUla Conference…

1 hour ago

Roches fenebrutinib is the first investigational medicine in over a decade that reduces disability progression in primary progressive multiple sclerosis (PPMS)

Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint…

1 hour ago

Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

February 06, 2026 17:17 ET  | Source: Lexicon Pharmaceuticals, Inc. THE WOODLANDS, Texas, Feb. 06,…

1 hour ago